Despite the emergence of several new sources of real-world evidence for healthcare in China, little has been done to evaluate these resources. A study published in Value in Health Regional Issues found that many of these databases are of insufficient quality to further health economics and outcomes research (HEOR) goals. Likewise, limited data access remains a stumbling block.
The authors of the study write, “Compared with similar databases in developed countries, the secondary databases in China have some general limitations such as variations in data quality, unclear data usage mechanism, and lack of longitudinal follow-up data. In contrast, the large sample size and the potential to collect additional data based on research needs present opportunities to further improve real-world data in China.”
Click here to read more.
(Source: Value in Health Regional Issues, January 1st, 2022)